The VP, Strategy of Stepan Company is Exercising Options

By Carrie Williams

Today, the VP, Strategy of Stepan Company, Frank Pacholec, exercised options of Stepan Company for $270.9K.

In addition to Frank Pacholec, 5 other SCL executives reported Sell trades in the last month.

Based on Stepan Company’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $474 million and quarterly net profit of $9.88 million. In comparison, last year the company earned revenue of $421 million and had a net profit of $8.42 million. The company has a one-year high of $92.97 and a one-year low of $68.75. SCL’s market cap is $1.94B and the company has a P/E ratio of 22.02.

The insider sentiment on Stepan Company has been negative according to 78 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Frank Pacholec’s trades have generated a -14.4% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Stepan Co. engages in the manufacturing and sale of specialty and intermediate chemicals. It operates through the following segments: Surfactants, Polymers, and Specialty Products. The Surfactants segment offers a range of surfactant chemicals such as anionic, cationic, nonionic, and amphoteric surfactants.